First Republic Investment Management, Inc. Halozyme Therapeutics, Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

A detailed history of First Republic Investment Management, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 13,323 shares of HALO stock, worth $608,194. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,323

Previous 22,138 39.82%

Holding current value

$608,194

Previous $798,000 36.34%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$36.46 - $44.03 $321,394 - $388,124	-8,815 Reduced 39.82%	13,323 $508,000
Q2 2023 Jul 28, 2023	SELL	$30.28 - $38.74 $3.25 Million - $4.16 Million	-107,269 Reduced 82.89%	22,138 $798,000
Q1 2023 May 11, 2023	SELL	$32.86 - $55.7 $733,632 - $1.24 Million	-22,326 Reduced 14.71%	129,407 $4.94 Million
Q4 2022 Feb 13, 2023	SELL	$40.06 - $59.44 $471,145 - $699,073	-11,761 Reduced 7.19%	151,733 $8.63 Million
Q3 2022 Nov 03, 2022	BUY	$38.53 - $51.78 $144,564 - $194,278	3,752 Added 2.35%	163,494 $6.47 Million
Q2 2022 Aug 16, 2022	SELL	$37.35 - $48.3 $1.76 Million - $2.28 Million	-47,208 Reduced 22.81%	159,742 $7.03 Million
Q1 2022 May 16, 2022	BUY	$31.97 - $41.06 $111,671 - $143,422	3,493 Added 1.72%	206,950 $8.25 Million
Q4 2021 Feb 09, 2022	BUY	$31.82 - $40.75 $1.25 Million - $1.6 Million	39,185 Added 23.85%	203,457 $8.18 Million
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $800,560 - $966,000	-20,810 Reduced 11.24%	164,272 $6.68 Million
Q2 2021 Aug 16, 2021	BUY	$38.84 - $51.31 $3.63 Million - $4.8 Million	93,562 Added 102.23%	185,082 $8.41 Million
Q1 2021 May 14, 2021	BUY	$39.51 - $51.45 $114,420 - $148,999	2,896 Added 3.27%	91,520 $3.82 Million
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $204,337 - $345,339	7,917 Added 9.81%	88,624 $3.79 Million
Q3 2020 Nov 12, 2020	BUY	$25.74 - $29.63 $6,589 - $7,585	256 Added 0.32%	80,707 $2.12 Million
Q2 2020 Aug 13, 2020	BUY	$16.25 - $26.81 $601,477 - $992,345	37,014 Added 85.21%	80,451 $2.16 Million
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $14,482 - $18,944	970 Added 2.28%	43,437 $770,000
Q3 2019 Nov 08, 2019	BUY	$15.2 - $17.69 $6,551 - $7,624	431 Added 1.03%	42,467 $659,000
Q2 2019 Aug 07, 2019	BUY	$14.75 - $17.26 $531 - $621	36 Added 0.09%	42,036 $722,000
Q4 2018 Feb 12, 2019	SELL	$13.33 - $18.66 $9,810 - $13,733	-736 Reduced 1.72%	42,000 $614,000
Q2 2018 Aug 14, 2018	SELL	$16.87 - $20.3 $38,379 - $46,182	-2,275 Reduced 5.05%	42,736 $721,000
Q1 2018 May 10, 2018	BUY	$17.06 - $21.2 $187 - $233	11 Added 0.02%	45,011 $882,000
Q4 2017 Feb 09, 2018	SELL	$16.75 - $20.8 $703,500 - $873,600	-42,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.76 - $17.4 $493,920 - $730,799	42,000	42,000 $730,000

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.36B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account

First Republic Investment Management, Inc. Halozyme Therapeutics, Inc. Transaction History